| 1C2K | date | ![]() |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||
| compound | source | ||||||||||||||
| symmetry |
| ||||||||||||||
| crystal cell |
| ||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||
| ligand | ABI, CA, CL, ZN | enzyme |
| ||||||||||||
| related structures | by homologous chain: 1P2I, 1V2M | ||||||||||||||
| Gene Ontology |
| ||||||||||||||
| Primary reference | Design of potent selective zinc-mediated serine protease inhibitors., Katz BA, Clark JM, Finer-Moore JS, Jenkins TE, Johnson CR, Ross MJ, Luong C, Moore WR, Stroud RM, Nature 1998 Feb 5;391(6667):608-12. PMID:9468142 | ||||||||||||||
| Data retrieval |
![]() |
| View 1C2K in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |